Zobrazeno 1 - 10
of 10
pro vyhledávání: '"van Bruggen JAC"'
Autor:
van Bruggen JAC; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Peters FS; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Mes M; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Rietveld JM; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Cerretani E; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Cretenet G; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., van Kampen R; Zuyderland Medical Center, Sittard-Geleen, The Netherlands., Jongejan A; Department of Epidemiology and Data Science, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Moerland PD; Department of Epidemiology and Data Science, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Melenhorst JJ; Cleveland Clinic, Lerner Research Institute, Center for Immunotherapy & Precision Immuno-Oncology, Cleveland, OH., van der Windt GJW; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Eldering E; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Kater AP; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Blood advances [Blood Adv] 2024 Sep 10; Vol. 8 (17), pp. 4633-4646.
Autor:
Waanders L; Department of Medical Microbiology and Infection Control, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, Netherlands., van der Donk LEH; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands., Ates LS; Department of Experimental Immunology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands., Maaskant J; Department of Medical Microbiology and Infection Control, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands., van Hamme JL; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands., Eldering E; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Cancer Immunology, Amsterdam, Netherlands.; The Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, Netherlands., van Bruggen JAC; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Cancer Immunology, Amsterdam, Netherlands., Rietveld JM; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Cancer Immunology, Amsterdam, Netherlands., Bitter W; Department of Medical Microbiology and Infection Control, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Amsterdam institute for Life and Environment, Vrije Universiteit, Amsterdam, Netherlands., Geijtenbeek TBH; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands c.kuijl@amsterdamumc.nl t.b.geijtenbeek@amsterdamumc.nl.; Department of Experimental Immunology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands., Kuijl CP; Department of Medical Microbiology and Infection Control, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands c.kuijl@amsterdamumc.nl t.b.geijtenbeek@amsterdamumc.nl.; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, Netherlands.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Apr; Vol. 11 (4).
Autor:
Chen Z; Experimental Immunology, and.; Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, The Netherlands., Simon-Molas H; Experimental Immunology, and.; Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, The Netherlands., Cretenet G; Experimental Immunology, and.; Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, The Netherlands., Valle-Argos B; Curve Therapeutics, University of Southampton, Southampton, UK.; Cancer Research UK Centre, Cancer Sciences, University of Southampton, Southampton, UK., Smith LD; Cancer Research UK Centre, Cancer Sciences, University of Southampton, Southampton, UK.; Ploughshare Innovations Limited, Porton Science Park, Porton Down, UK., Forconi F; Department of Haematology, Southampton University Hospital Trust, Southampton, UK., Schomakers BV; Laboratory Genetic Metabolic Diseases, and.; Core Facility Metabolomics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands., van Weeghel M; Laboratory Genetic Metabolic Diseases, and.; Core Facility Metabolomics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands., Bryant DJ; Cancer Research UK Centre, Cancer Sciences, University of Southampton, Southampton, UK., van Bruggen JAC; Experimental Immunology, and.; Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, The Netherlands., Peters FS; Experimental Immunology, and.; Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, The Netherlands., Rathmell JC; Vanderbilt Center for Immunobiology, Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., van der Windt GJW; Genmab, Utrecht, The Netherlands; and., Kater AP; Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center, Amsterdam, The Netherlands., Packham G; Cancer Research UK Centre, Cancer Sciences, University of Southampton, Southampton, UK., Eldering E; Experimental Immunology, and.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center, Amsterdam, The Netherlands.
Publikováno v:
Blood [Blood] 2022 Aug 11; Vol. 140 (6), pp. 630-643.
Autor:
van Bruggen JAC; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands; and., van der Windt GJW; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands; and., Hoogendoorn M; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Dubois J; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands; and., Kater AP; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands; and., Peters FS; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands; and.
Publikováno v:
Blood advances [Blood Adv] 2022 Jul 26; Vol. 6 (14), pp. 4185-4195.
Autor:
van Bruggen JAC; Department of Hematology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, 1105 AZ Amsterdam, The Netherlands., Martens AWJ; Department of Hematology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, 1105 AZ Amsterdam, The Netherlands., Tonino SH; Department of Hematology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, 1105 AZ Amsterdam, The Netherlands., Kater AP; Department of Hematology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, 1105 AZ Amsterdam, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Sep 22; Vol. 13 (19). Date of Electronic Publication: 2021 Sep 22.
Autor:
Hofland T; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Martens AWJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van Bruggen JAC; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., de Boer R; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Schetters S; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Amsterdam, The Netherlands., Remmerswaal EBM; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Renal Transplant Unit, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bemelman FJ; Renal Transplant Unit, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Bins AD; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Eldering E; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands., Kater AP; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands., Tonino SH; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands.
Publikováno v:
European journal of immunology [Eur J Immunol] 2021 Mar; Vol. 51 (3), pp. 703-713. Date of Electronic Publication: 2020 Nov 23.
Autor:
van Bruggen JAC; Department of Hematology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, 1105 AZ Amsterdam, The Netherlands., Martens AWJ; Department of Hematology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, 1105 AZ Amsterdam, The Netherlands., Tonino SH; Department of Hematology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, 1105 AZ Amsterdam, The Netherlands., Kater AP; Department of Hematology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, 1105 AZ Amsterdam, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Dec 18; Vol. 12 (12). Date of Electronic Publication: 2020 Dec 18.
Autor:
van der Schoot JMS; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands., Fennemann FL; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands., Valente M; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands., Dolen Y; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands., Hagemans IM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands., Becker AMD; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands., Le Gall CM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands., van Dalen D; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands., Cevirgel A; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands., van Bruggen JAC; Division of Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands., Engelfriet M; Division of Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands., Caval T; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, Netherlands., Bentlage AEH; Sanquin Research, Department of Experimental Immunohematology, Amsterdam, The Netherlands, and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Plesmanlaan 125, Amsterdam 1066 CX, Netherlands., Fransen MF; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333 ZA Leiden, Netherlands., Nederend M; Laboratory for Translational Immunology, UMC Utrecht, Utrecht, Netherlands., Leusen JHW; Laboratory for Translational Immunology, UMC Utrecht, Utrecht, Netherlands., Heck AJR; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, Netherlands., Vidarsson G; Sanquin Research, Department of Experimental Immunohematology, Amsterdam, The Netherlands, and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Plesmanlaan 125, Amsterdam 1066 CX, Netherlands., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands., Verdoes M; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands., Scheeren FA; Department of Medical Oncology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333 ZA Leiden, Netherlands.
Publikováno v:
Science advances [Sci Adv] 2019 Aug 28; Vol. 5 (8), pp. eaaw1822. Date of Electronic Publication: 2019 Aug 28 (Print Publication: 2019).
Autor:
van Bruggen JAC; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, The Netherlands., Martens AWJ; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, The Netherlands., Fraietta JA; Department of Pathology and Laboratory Medicine.; Department of Microbiology.; Center for Cellular Immunotherapies, and.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Hofland T; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, The Netherlands., Tonino SH; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and., Eldering E; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Siska PJ; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany; and., Endstra S; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, The Netherlands., Rathmell JC; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., June CH; Department of Pathology and Laboratory Medicine.; Center for Cellular Immunotherapies, and., Porter DL; Department of Pathology and Laboratory Medicine., Melenhorst JJ; Department of Pathology and Laboratory Medicine.; Center for Cellular Immunotherapies, and., Kater AP; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and., van der Windt GJW; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, The Netherlands.
Publikováno v:
Blood [Blood] 2019 Jul 04; Vol. 134 (1), pp. 44-58. Date of Electronic Publication: 2019 May 10.
Autor:
van Attekum MHA; Department of Hematology, Academic Medical Center, University of Amsterdam; the Netherlands.; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam; the Netherlands., van Bruggen JAC; Department of Hematology, Academic Medical Center, University of Amsterdam; the Netherlands.; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam; the Netherlands., Slinger E; Department of Hematology, Academic Medical Center, University of Amsterdam; the Netherlands.; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam; the Netherlands., Lebre MC; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam; the Netherlands., Reinen E; Department of Hematology, Academic Medical Center, University of Amsterdam; the Netherlands.; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam; the Netherlands., Kersting S; Department of Hematology, Haga Teaching Hospital, The Hague, the Netherlands., Eldering E; Department of Hematology, Haga Teaching Hospital, The Hague, the Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), the Netherlands., Kater AP; Department of Hematology, Academic Medical Center, University of Amsterdam; the Netherlands a.p.kater@amc.nl.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), the Netherlands.
Publikováno v:
Haematologica [Haematologica] 2017 Dec; Vol. 102 (12), pp. 2069-2076. Date of Electronic Publication: 2017 Sep 29.